01 · Identify
Find the decision at risk
Use the Decision Documentation Assessment to identify where a consequential decision still depends on undocumented reasoning, fragmented evidence, or unavailable people.
Artifact · Executive assessment result
Pharmaceutical compliance · GMP · FDA inspection readiness
Can you defend the decisions behind your quality records?
Your QMS can show that a deviation closed, a batch was released, or a CAPA was deemed effective. ComplianceWorxs preserves the part later scrutiny still needs: who authorized the decision, what evidence they reviewed, what risk remained, and why the decision was reasonable at the time.
About 3 minutes · No documents required · No email, account, or sales call
Built for accountable review
QA Directors, Quality Leaders, Validation Leads, Regulatory Affairs, and executive sponsors
Starts with
The records you already have
Preserves
Evidence · Judgment · Risk · Authorization
Does not do
Make or approve the regulated decision for you
Executive exposure
The problem is not that the record is missing. It is that the decision behind the record may be impossible to inspect.
A completed workflow can prove what happened without preserving the evidence, reasoning, risk judgment, and accountable authorization that explain why the organization proceeded.
| What the system can show | What scrutiny can still ask | Executive exposure |
|---|---|---|
| The CAPA was closed | Who judged it effective, using what evidence and observation period? | Closure without a durable decision basis |
| The batch was dispositioned | Who authorized release and what quality criteria were evaluated? | Approval distributed across records and memory |
| The deviation was closed | Who accepted the residual risk, and why was that reasonable then? | Signature without reviewable reasoning |
The executive question: if the original team were unavailable tomorrow, could another qualified person understand and defend the decision from the record alone?
What ComplianceWorxs changes
One record that makes a consequential decision inspectable.
ComplianceWorxs does not replace the QMS. It preserves the decision context that conventional quality records can leave scattered across documents, meetings, inboxes, and institutional memory.
Conventional quality record
- Confirms an event occurred
- Contains status, signatures, and attachments
- May reference supporting evidence
- Shows closure or approval
- Can become harder to explain as context fades
ComplianceWorxs Inspection Response Record
- Preserves the decision behind the event
- Identifies the accountable authorizer
- Records the evidence actually evaluated
- Captures judgment, risk, limitations, rationale, and accepted treatment
- Creates a durable record another qualified reviewer can inspect later
Operating model
From inspection exposure to a defensible record.
The path is deliberately short: identify one completed decision, inspect what the existing record can support, then preserve accountable authorization.
02 · Inspect
Review the decision context
Start with the record you already have. Establish what it supports, what is material but missing, and which questions later scrutiny could expose.
Artifact · Decision review
03 · Preserve
Record accountable authorization
The authorized person reviews bounded treatment options and accepts the treatment. The finished IRR preserves the decision for later scrutiny.
Artifact · Inspection Response Record
Executive summary
What changes for the accountable quality leader.
The value is not more documentation. It is less reconstruction when a consequential decision is challenged.
Find the authority, evidence basis, and decision logic without rebuilding the story from fragmented records.
Distinguish a completed workflow from a decision authorized by a named accountable person.
Preserve rationale before turnover, elapsed time, and organizational change erode context.
Surface missing evidence, unresolved risk, and material limitations before later scrutiny forces reconstruction.
Business exposure
Consequential GMP decisions can outlive the people and context that made them understandable.
Control introduced
A reviewer-ready record connecting evidence, judgment, risk, limitations, reasoning, and human authorization.
Executive outcome
A decision that can be reviewed later without depending on institutional memory or a reconstructed narrative.
Lowest-friction next step
Assess one completed decision. No documents are uploaded or inspected.
See the exposure in context
The same decision-record problem appears across familiar quality events.
Inspect a scenario only if it matches the decision you own.
Pharmaceutical compliance
Pharmaceutical compliance documents what happened. The record behind the decision shows why it was authorized.
GMP, cGMP and GxP programs, data integrity controls, your QMS, and your quality assurance and quality control functions all produce records. FDA warning letters and inspection observations can turn on a narrower question: was the quality decision investigated, justified, and documented when it was made?
| Where you meet it | What scrutiny asks | What the record behind the decision preserves |
|---|---|---|
| GMP and cGMP | Who in the quality unit authorized the release, the CAPA closure, or the deviation disposition, under which SOP, and why was it reasonable? | The evidence considered, the judgment applied, the risk accepted, and the named authorizer. |
| CAPA and root cause analysis | Who judged the root cause analysis sufficient and the CAPA effective, and on what evidence and observation period? | The evidence evaluated, the judgment applied, and the accountable authorization behind the closure. |
| Quality assurance and quality control | When QC results and the QA review had to be reconciled, who decided, and why? | The reasoning that connected the QC evidence to the QA disposition, with the named authorizer. |
| Validation | Who concluded the validation evidence supported the change, and what risk was accepted? | The evidence, the risk management decision, and the authorization behind the validation conclusion. |
| GxP | Can a regulated decision be understood from the record alone, across the quality events you own? | One reviewer-ready record per consequential decision, instead of reasoning spread across systems and inboxes. |
| Data integrity | Is the record attributable and contemporaneous, or was the rationale reconstructed after the fact? | The evidence, reasoning, and named authorization preserved together and dated, so the rationale is on record before anyone has to reconstruct it. |
| FDA warning letters | Was the decision behind the response adequately investigated and justified? | The authorization reasoning an inspector can read, ready before the question is asked. |
| Drug recall | If a released batch is later questioned or recalled, can the original release decision be explained? | The authorization reasoning behind the release, preserved before it is needed. |
| ISO 13485 and ISO 9001 | Can an auditor trace a quality decision to its evidence and its accountable owner? | The same decision record, held alongside your existing quality system rather than replacing it. |
Where this sits: ComplianceWorxs does not replace your QMS or your validation, CAPA, or deviation systems. They preserve what happened. The Inspection Response Record preserves why the decision was authorized. It is built for pharmaceutical, biotech, and life sciences Quality, Validation, and Regulatory Affairs teams.
Assess one completed decision before you need to defend it.
See where the record can stand on its own—and where it would still require reconstruction.
About 3 minutes · No documents required · No email, account, or sales call